Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Neurocardiac Control in Major Depression
The National Institute of Mental Health-sponsored trial on neurocardiac control in major depressive disorder has completed.
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for quetiapine from Accord Healthcare Inc. (ANDA 202152).
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate (Quetiapine) by BluePoint Laboratories under an existing ANDA. This represen…
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., granting approval of a generic sustain…
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride sustained-release from ScieGen Pharmaceuticals, Inc. (ANDA 206122). …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Epic Pharma, LLC)
FDA approves Epic Pharma's generic bupropion hydrochloride extended-release tablets (Bupropion HCl XL) under an Original Application, adding…
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate by Alembic Pharmaceuticals Limited.
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market quetiapine fumarate. The approval covers a generic ve…
-
FDA approval · 2017-06-28FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the Original Application for doxepin hydrochloride by Amneal Pharmaceuticals NY LLC, confirming approval of this generic produc…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment [Phase 3]
Phase 3 trial update evaluating the safety of adjunct brexpiprazole in elderly patients with major depressive disorder who had an inadequate…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Evaluation of a Mental Health Physician Support Program in Nova Scotia [NA]
Completed clinical trial evaluating a Mental Health Physician Support Program in Nova Scotia; results posted in 2017.
-
FDA label_change · 2017-06-22FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for quetiapine (generic), updating the drug's labeling under the approved ANDA.
-
FDA approval · 2017-06-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for quetiapine fumarate by Hikma Pharmaceuticals USA Inc., representing a new or updated approval fo…
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating Wuling Powder for depressive symptoms in Parkinson's disease. The study also investigates potential underl…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Depression, Adversity, and Stress Hormones (DASH) Study [NA]
The DASH study on depression, adversity, and stress hormones has completed. The update notes completion of the trial, with no efficacy resul…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Dexamethasone and Ketamine on Change of Postoperative Mood [Phase 4]
Phase 4 clinical trial evaluating the combined effects of dexamethasone and ketamine on postoperative mood in patients with depressive sympt…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder [NA]
An eight-week exercise intervention is being studied for Major Depressive Disorder in a clinical trial, with the status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression [NA]
This ClinicalTrials.gov entry reports the completion of a randomized controlled trial evaluating in-home tele-behavioral health care using B…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Shared Decision-Making for Elderly Depressed Primary Care Patients [NA]
A completed clinical trial evaluated shared decision-making for elderly depressed patients in primary care. Results were posted on 2017-06-1…
-
FDA approval · 2017-06-15FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG, indicating an approved modification to th…
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Intervention Strategy in Chronic Obstructive Pulmonary Disease With Anxiety and Depression [NA]
This clinical trial entry (NCT03187249) describes an intervention strategy for chronic obstructive pulmonary disease patients with anxiety a…
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment [NA]
A completed clinical trial evaluating pre-treatment PET scanning to improve antidepressant treatment success in depression.
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China
A clinical trial registry entry for a study on chronic obstructive pulmonary disease with coexisting anxiety and depression in China; sponso…
-
FDA approval · 2017-06-12FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, granting generic drug status for this API…
-
FDA approval · 2017-06-12FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Bupropion hydrochloride extended-release (XL) from Exelan Pharmaceuticals Inc.